MarkWilliamHamblinMD

PubMed

• Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms.
  Guthrie, C. R.,Murray, A. T.,Franklin, A. A.,Hamblin, M. W.> ;J Pharmacol Exp Ther. 2005 Jun
• Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors.
  Béïque, J. C., Campbell, B., Perring, P., Hamblin, M. W., Walker, P., Mladenovic, L., Andrade, R.> ;J Neurosci. 2004 May 19
• Congenitally learned helpless rats show abnormalities in intracellular signaling
  Ruth Kohen, John F. Neumaier, Mark W. Hamblin, Emmeline Edwards> ;Biological Psychiatry. 2003 Mar 15
• Regulation of 5-HT2 and 5-HT1C serotonin receptor levels. Methodology and mechanisms.
  Roth BL, Hamblin M, Ciaranello RD> ;Neuropsychopharmacology. 1990-01-01
• Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
  Leff SE, Hamblin MW, Creese I> ;Mol. Pharmacol.. 1985-02-01
• Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
  Hamblin MW, Leff SE, Creese I> ;Biochem. Pharmacol.. 1984-03-15
• Dopamine receptors in the central nervous system.
  Creese I, Sibley DR, Hamblin MW, Leff SE> ;Adv. Biochem. Psychopharmacol.. 1983-01-01
• The classification of dopamine receptors: relationship to radioligand binding.
  Creese I, Sibley DR, Hamblin MW, Leff SE> ;Annu. Rev. Neurosci.. 1983-01-01
• Dopamine receptors in the central nervous system.
  Creese I, Morrow AL, Leff SE, Sibley DR, Hamblin MW> ;Int. Rev. Neurobiol.. 1982-01-01
• Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
  Hamblin MW, Creese I> ;Mol. Pharmacol.. 1982-01-01
• Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
  Hamblin MW, Creese I> ;Mol. Pharmacol.. 1982-01-01
• Phenoxybenzamine discriminates multiple dopamine receptors
  Mark W. Hamblin, Ian Creese> ;European Journal of Pharmacology. 1980 Jul 11
• G protein dependent alterations in [125I]iodocyanopindolol and +/- cyanopindolol binding at 5-HT1B binding sites in rat brain membranes.
  Ariani, K., Hamblin, M. W., Tan, G. L., Stratford, C. A., Ciaranello, R. D.> ;Neurochem Res. 1989 Sep
• Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry.
  Ward, R. P., Hamblin, M. W., Lachowicz, J. E., Hoffman, B. J., Sibley, D. R., Dorsa, D. M.> ;Neuroscience. 1995 Feb
• The structure and signalling properties of 5-HT receptors: an endless diversity?
  Martin, G. R., Eglen, R. M., Hamblin, M. W., Hoyer, D., Yocca, F.> ;Trends Pharmacol Sci. 1998 Jan
• Developmental regulation of 5-HT2 and 5-HT1c mRNA and receptor levels.
  Roth, B. L., Hamblin, M. W., Ciaranello, R. D.> ;Brain Res Dev Brain Res. 1991 Jan 15
• Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor.
  Hamblin, M. W., Metcalf, M. A.> ;Mol Pharmacol. 1991 Aug
• Blunting of the neurotensin mRNA response to haloperidol in the striatum of aging rats: possible relationship to decline in dopamine D2 receptor expression.
  Dobie, D. J., Merchant, K. M., Hamblin, M. W., Vatassery, G. T., Dysken, M. W., Dorsa, D. M.> ;Brain Res. 1993 Jul 9
• Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
  Monsma, F. J., Shen, Y., Ward, R. P., Hamblin, M. W., Sibley, D. R.> ;Mol Pharmacol. 1993 Mar
• Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor.
  Baker, L. P., Nielsen, M. D., Impey, S., Metcalf, M. A., Poser, S. W., Chan, G., Obrietan, K., Hamblin, M. W., Storm, D. R.> ;J Biol Chem. 1998 Jul 10
• Conversion of the human 5-HT1D beta serotonin receptor to the rat 5-HT1B ligand-binding phenotype by Thr355Asn site directed mutagenesis.
  Metcalf, M. A., McGuffin, R. W., Hamblin, M. W.> ;Biochem Pharmacol. 1992 Nov 17
• Distinct 5-HT(1B) and 5-HT(1D) serotonin receptors in rat: Structural and pharmacological comparison of the two cloned receptors.
  Hamblin, M. W., McGuffin, R. W., Metcalf, M. A., Dorsa, D. M., Merchant, K. M.> ;Mol Cell Neurosci. 1992 Dec 01
• Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
  Shen, Y., Monsma, F. J., Metcalf, M. A., Jose, P. A., Hamblin, M. W., Sibley, D. R.> ;J Biol Chem. 1993 Aug 25
• Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop.
  Kohen, R., Fashingbauer, L. A., Heidmann, D. E., Guthrie, C. R., Hamblin, M. W.> ;Brain Res Mol Brain Res. 2001 Jun 20
• Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
  Stratford, C. A., Tan, G. L., Hamblin, M. W., Ciaranello, R. D.> ;Mol Pharmacol. 1988 Oct
• Join now to see all